Counterfeit Botox imported from Hong Kong, FDA reveals
The Food and Drug Administration (FDA) urged people to check product packaging carefully to avoid counterfeit goods, after several boxes of imported botulinum toxin injectable products were found to be counterfeit products that contained no botulinum toxin.
A package labeled as containing 11 boxes of botulinum toxin type A product — or Allergan’s Botox — sent from Hong Kong was intercepted by the Customs Administration and sent to the FDA for examination.
http://www.taipeitimes.com/News/taiwan/archives/2016/03/13/2003641480
Related Posts
Pack Expo 2013: new anti-counterfeit and coding technology
Last month's Pack Expo in Las Vegas saw the launch of a several new products with...
Tobacco firms rue weak anti-smuggling campaign
The domestic tobacco industry hopes that the Government can be more effective in...
Cops seize over Dh100 million worth of fake goods in UAE.
04, November 2018 | Khaleej Times More than Dh100 million worth of...
Diesel Speeds Up Measures Against Counterfeiting
Diesel has started a comprehensive offensive strategy to protect its brand. Since...


